These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 12516287)
1. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects]. Peces R; Olea T Nefrologia; 2002; 22(6):540-6. PubMed ID: 12516287 [TBL] [Abstract][Full Text] [Related]
2. Clinical features of and recent advances in therapy for Fabry disease. Brady RO; Schiffmann R JAMA; 2000 Dec; 284(21):2771-5. PubMed ID: 11105184 [TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of Anderson Fabry disease in a Romanian family. Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of patients with Fabry disease in Argentina]. AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales) Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022 [TBL] [Abstract][Full Text] [Related]
12. [Anderson-Fabry disease]. Kes P; Basić-Jukić N; Brunetta B; Jurić I Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573 [TBL] [Abstract][Full Text] [Related]
13. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124 [TBL] [Abstract][Full Text] [Related]
14. Renal involvement in Anderson-Fabry disease. Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774 [TBL] [Abstract][Full Text] [Related]
15. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors. Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680 [TBL] [Abstract][Full Text] [Related]
16. Disease manifestations and X inactivation in heterozygous females with Fabry disease. Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462 [TBL] [Abstract][Full Text] [Related]
17. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease. Mirceva V; Hein R; Ring J; Möhrenschlager M Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840 [TBL] [Abstract][Full Text] [Related]